Item 1. Legal Proceedings
85K characters. Original on sec.gov ·
Item 1. Legal Proceedings
| Note 12 : | Contingencies |
Legal Proceedings
We are regularly party to various ongoing claims, litigation, and other proceedings, including those noted in this section. We have accrued a charge of $2.2 billion related to litigation involving VLSI, described below. Excluding the VLSI claims described below, management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends; however, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings, excessive verdicts, or other events could occur. Unfavorable resolutions could include substantial monetary damages, fines, or penalties. Certain of these outstanding matters include speculative, substantial, or indeterminate monetary awards. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Except as specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time.
![]() | Financial Statements | Notes to Financial Statements | 18 |
European Commission Competition Matter
In 2009, the European Commission (EC) found that Intel had used unfair business practices to persuade customers to buy microprocessors in violation of Article 82 of the EC Treaty (later renumbered Article 102) and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 by offering alleged “conditional rebates and payments” that required customers to purchase all or most of their x86 microprocessors from us and by making alleged “payments to prevent sales of specific rival products.” The EC ordered us to end the alleged infringement referred to in its decision and imposed a €1.1 billion fine, which we paid in the third quarter of 2009.
We appealed the EC decision to the European Court of Justice in 2014, after the General Court (then called the Court of First Instance) rejected our appeal of the EC decision in its entirety. In September 2017, the Court of Justice sent the case back to the General Court to examine whether the rebates at issue were capable of restricting competition.
In January 2022, the General Court annulled the EC’s 2009 findings against Intel regarding rebates, as well as the fine imposed on Intel, which was returned to us in February 2022. In April 2022, the EC appealed the General Court’s decision to the Court of Justice. A hearing date on the appeal has not been scheduled. The General Court’s January 2022 decision did not annul the EC’s 2009 finding that Intel made payments to prevent sales of specific rival products, and in January 2023 the EC reopened its administrative procedure to determine a fine against Intel based on that alleged conduct. Given the procedural posture and the nature of this proceeding, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from this matter.
In a related matter, in April 2022 we filed applications with the General Court seeking an order requiring the EC to pay Intel approximately €593 million in default interest, which applications have been stayed pending the EC’s appeal of the General Court’s January 2022 decision.
Litigation Related to Security Vulnerabilities
In June 2017, a Google research team notified Intel and other companies that it had identified security vulnerabilities, now commonly referred to as “Spectre” and “Meltdown,” that affect many types of microprocessors, including our products. As is standard when findings like these are presented, we worked together with other companies in the industry to verify the research and develop and validate software and firmware updates for impacted technologies. In January 2018, information on the security vulnerabilities was publicly reported before software and firmware updates to address the vulnerabilities were made widely available.
Numerous lawsuits have been filed against Intel relating to Spectre, Meltdown, and other variants of the security vulnerabilities that have been identified since 2018. As of January 25, 2023, consumer class action lawsuits against Intel were pending in the United States, Canada, and Argentina. The plaintiffs, who purport to represent various classes of purchasers of our products, generally claim to have been harmed by Intel's actions and/or omissions in connection with the security vulnerabilities and assert a variety of common law and statutory claims seeking monetary damages and equitable relief. In the United States, class action suits filed in various jurisdictions were consolidated for all pretrial proceedings in the US District Court for the District of Oregon, which entered final judgment in favor of Intel in July 2022 based on plaintiffs’ failure to plead a viable claim. Plaintiffs have appealed that decision to the Ninth Circuit Court of Appeals. In Canada, an initial status conference has not yet been scheduled in one case pending in the Superior Court of Justice of Ontario, and a stay of a second case pending in the Superior Court of Justice of Quebec is in effect. In Argentina, Intel Argentina was served with, and responded to, a class action complaint in June 2022. Additional lawsuits and claims may be asserted seeking monetary damages or other related relief. We dispute the pending claims described above and intend to defend those lawsuits vigorously. Given the procedural posture and the nature of those cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from those matters.
Litigation Related to 7nm Product Delay Announcement
Multiple securities class action lawsuits were filed in the US District Court for the Northern District of California against Intel and certain officers following Intel’s July 2020 announcement of 7nm product delays. The court consolidated the lawsuits and appointed lead plaintiffs in October 2020, and in January 2021 plaintiffs filed a consolidated complaint. Plaintiffs purport to represent all persons who purchased or otherwise acquired Intel common stock from October 25, 2019 through October 23, 2020, and they generally allege that defendants violated the federal securities laws by making false or misleading statements about the timeline for 7nm products. In March 2023, the court granted defendants’ motion to dismiss the consolidated complaint, with leave to amend. Given the procedural posture and the nature of the case, including that it is in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class being certified or the ultimate size of any class if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from the matter. In July 2021, Intel introduced a new process node naming structure, and the 7nm process is now called Intel 4.
![]() | Financial Statements | Notes to Financial Statements | 19 |
Litigation Related to Patent and IP Claims
We have had IP infringement lawsuits filed against us, including but not limited to those discussed below. Most involve claims that certain of our products, services, and technologies infringe others' IP rights. Adverse results in these lawsuits may include awards of substantial fines and penalties, costly royalty or licensing agreements, or orders preventing us from offering certain features, functionalities, products, or services. As a result, we may have to change our business practices, and develop non-infringing products or technologies, which could result in a loss of revenue for us and otherwise harm our business. In addition, certain agreements with our customers require us to indemnify them against certain IP infringement claims, which can increase our costs as a result of defending such claims, and may require that we pay significant damages, accept product returns, or supply our customers with non-infringing products if there were an adverse ruling in any such claims. In addition, our customers and partners may discontinue the use of our products, services, and technologies, as a result of injunctions or otherwise, which could result in loss of revenue and adversely affect our business.
VLSI Technology LLC v. Intel
In October 2017, VLSI Technology LLC (VLSI) filed a complaint against Intel in the US District Court for the Northern District of California alleging that various Intel FPGA and processor products infringe eight patents that VLSI acquired from NXP Semiconductors, N.V. (NXP). Four patents remain at issue in the case, and VLSI estimates its damages to be approximately $900 million, and seeks enhanced damages, future royalties, attorneys’ fees, costs, and interest. Intel filed Inter Partes Review (IPR) petitions with the Patent Trial and Appeal Board (PTAB) in 2018 challenging patentability, and the parties stipulated to stay the district court action pending the PTAB's review. The PTAB subsequently found all claims of two patents, and some claims of two other patents, to be unpatentable. The district court lifted the stay in September 2021 and scheduled trial for March 2024 on the claims that were found patentable by the PTAB.
In June 2018, VLSI filed a second suit against Intel, in US District Court for the District of Delaware, seeking $4.4 billion in damages for the alleged infringement by various Intel processors of five additional patents that VLSI acquired from NXP. In December 2022, VLSI stipulated to dismiss with prejudice its claims, for which Intel paid nothing. The court dismissed the case in January 2023.
In April 2019, VLSI filed three infringement suits against Intel in the US District Court for the Western District of Texas accusing various Intel processors of infringement of eight additional patents it had acquired from NXP. The first Texas case went to trial in February 2021, and the jury awarded VLSI $1.5 billion for literal infringement of one patent and $675 million for infringement of another patent under the doctrine of equivalents. In April 2022, the court entered final judgment, awarding VLSI $2.2 billion in damages and approximately $162.3 million in pre-judgment and post-judgment interest. Intel has appealed the judgment to the Federal Circuit Court of Appeals, including its claim to have a license from Fortress Investment Group’s acquisition of Finjan. In December 2021 and January 2022, the PTAB instituted IPRs on the claims found to have been infringed in the first Texas case, but it has not yet issued a final written decision on either petition.
The second Texas case went to trial in April 2021, and the jury found that Intel does not infringe the asserted patents. VLSI had sought approximately $3.0 billion for alleged infringement, plus enhanced damages for willful infringement. The court has not yet entered final judgment following the second trial in Texas. The third Texas case went to trial in November 2022, with VLSI asserting one remaining patent. The jury found the patent valid and infringed, and awarded VLSI approximately $949 million in damages, plus a running royalty. The court has not yet entered final judgment following the third trial in Texas. In February 2023, Intel filed motions for a new trial and for judgment as a matter of law notwithstanding the verdict on various grounds. Further appeals are possible.
In May 2019, VLSI filed a case in Shenzhen Intermediate People’s Court against Intel, Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. VLSI asserts one patent against certain Intel Core processors. Defendants filed an invalidation petition in October 2019 with the China National Intellectual Property Administration (CNIPA), which held a hearing in September 2021. CNIPA has not yet issued a decision. The Shenzhen court held trial proceedings in July 2021 and stated that further trial proceedings were needed but would be stayed pending the outcome of defendants’ invalidity challenge at the CNIPA. VLSI seeks an injunction as well as RMB 1.3 million in costs and expenses, but no damages.
In May 2019, VLSI filed a case in Shanghai Intellectual Property Court against Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. asserting one patent against certain Intel core processors. The court held a trial hearing in December 2020, where VLSI requested expenses (RMB 300 thousand) and an injunction. The court held a second trial hearing in May 2022, but has yet to issue its final decision. In December 2022, Intel filed a second petition to invalidate the patent at issue.
Intel has accrued a charge of approximately $2.2 billion related to the VLSI litigation. While we dispute VLSI’s claims and intend to vigorously defend against them, we are unable to make a reasonable estimate of losses in excess of recorded amounts given recent developments and future proceedings.
![]() | Financial Statements | Notes to Financial Statements | 20 |
| Key Terms | |||||
We use terms throughout our document that are specific to Intel or that are abbreviations that may not be commonly known or used. Below is a list of these terms used in our document.
| Term | Definition | |||||||||||||
| 5G | The fifth-generation mobile network, which brings dramatic improvements in network speeds and latency, and which we view as a transformative technology and opportunity for many industries | |||||||||||||
| ADAS | Advanced driver-assistance systems | |||||||||||||
| ASP | Average selling price | |||||||||||||
| AXG | Advanced Computing and Graphics operating segment | |||||||||||||
| CCG | Client Computing Group operating segment | |||||||||||||
| CODM | Chief operating decision maker | |||||||||||||
| CPU | Processor or central processing unit | |||||||||||||
| DCAI | Data Center and Artificial Intelligence operating segment | |||||||||||||
| EC | European Commission | |||||||||||||
| EPS | Earnings per share | |||||||||||||
| Form 10-K | Annual Report on Form 10-K for the year ended December 31, 2022 | |||||||||||||
| Form 10-Q | Quarterly Report on Form 10-Q for the quarter ended April 1, 2023 | |||||||||||||
| FPGA | Field-programmable gate array | |||||||||||||
| GPU | Graphics processing unit | |||||||||||||
| IDM | Integrated device manufacturer, a semiconductor company that both designs and builds chips | |||||||||||||
| IFS | Intel Foundry Services operating segment | |||||||||||||
| IP | Intellectual property | |||||||||||||
| IPO | Initial public offering | |||||||||||||
| MD&A | Management's Discussion and Analysis | |||||||||||||
| MG&A | Marketing, general, and administrative | |||||||||||||
| MNC | Multinational corporation | |||||||||||||
| NAND | NAND flash memory | |||||||||||||
| Network Xeon | Part of the Intel Xeon processor family designed for network and edge solutions | |||||||||||||
| NEX | Networking and Edge operating segment | |||||||||||||
| nm | Nanometer | |||||||||||||
| ODM | Original design manufacturer | |||||||||||||
| R&D | Research and development | |||||||||||||
| RSU | Restricted stock unit | |||||||||||||
| SEC | US Securities and Exchange Commission | |||||||||||||
| SoC | A system on a chip, which integrates most of the components of a computer or other electronic system into a single silicon chip. We offer a range of SoC products in CCG, DCAI, and NEX. In our DCAI and NEX businesses, we offer SoCs across many market segments for a variety of applications, including products targeted for 5G base stations and network infrastructure | |||||||||||||
| SSD | Solid-state drive | |||||||||||||
| US | United States | |||||||||||||
| US GAAP | US Generally Accepted Accounting Principles | |||||||||||||
| VIE | Variable interest entity | |||||||||||||
| VLSI | VLSI Technology LLC | |||||||||||||
| vRAN | Virtualized radio access network | |||||||||||||
![]() | Financial Statements | Notes to Financial Statements | 21 |
| Management's Discussion and Analysis | |||||
This report should be read in conjunction with the Consolidated Financial Statements in our Form 10-K where we include additional information on our business, operating segments, risk factors, critical accounting estimates, policies, and the methods and assumptions used in our estimates, among other important information.
We previously announced the organizational change to integrate AXG into CCG and DCAI to drive a more effective go-to-market capability, accelerating the scale of these businesses while further reducing costs. As a result, we modified our segment reporting in the first quarter of 2023 to align to this and certain other business reorganizations. All prior-period segment data has been retrospectively adjusted to reflect the way we internally manage and monitor segment performance starting in fiscal year 2023.
"Note 2: Operating Segments” within Notes to Consolidated Condensed Financial Statements of this Form 10-Q reconciles our segment revenues presented below to our total revenues, and our segment operating margin (loss) presented below to our total operating margin (loss), for each of the periods presented.
For additional key highlights of our results of operations, see "A Quarter in Review."
Client Computing
We are committed to advancing PC experiences by delivering an annual cadence of leadership products and deepening our relationships with industry partners to co-engineer and deliver leading platform innovation. We engage in an intentional effort focused on a long-term operating system, system architecture, hardware, and application integration that enables industry-leading PC experiences. We will embrace these opportunities by simplifying and focusing our roadmap, ramping PC capabilities even more aggressively, and designing PC experiences even more deliberately. By doing this, we believe we will continue to fuel innovation across Intel, providing a growing source of IP, scale, and cash flow.
| CCG Revenue $B | CCG Operating Income $B |


| ■ Notebook | ■ Desktop | ■ Other |
| Revenue Summary |
| Q1 2023 vs. Q1 2022 |
**▪**Notebook revenue was $3.4 billion, down $2.6 billion from Q1 2022. Notebook volume decreased 37% in Q1 2023 due to customers tempering purchases to reduce existing inventories and due to lower demand. Notebook ASPs decreased 9% in Q1 2023 due to a higher mix of small core and older generation products.
**▪**Desktop revenue was $1.9 billion, down $762 million from Q1 2022. Desktop volume decreased 32% in Q1 2023, driven by lower demand in the small and medium business and education market segments, and due to customers tempering purchases to reduce existing inventories. Desktop ASPs increased 5% in Q1 2023 due to an increased mix of commercial and gaming products.
**▪**Other revenue was $481 million, down $241 million from Q1 2022, primarily driven by lower demand for our wireless and connectivity products.
![]() | MD&A | 22 |
| Operating Income Summary |
Operating income decreased 81% from Q1 2022, with an operating margin of 9%.
| (In Millions) | ||||||||
| $ | 520 | Q1 2023 CCG Operating Income | ||||||
| (2,358) | Lower product margin primarily from notebook and desktop revenue | |||||||
| (164) | Higher desktop unit cost primarily from increased mix of Intel 7 products | |||||||
| (120) | Higher period charges related to excess capacity charges | |||||||
| 251 | Lower period charges primarily driven by a decrease in product ramp costs | |||||||
| 200 | Lower operating expenses driven by various cost-cutting measures | |||||||
| (11) | Other | |||||||
| $ | 2,722 | Q1 2022 CCG Operating Income |
![]() | MD&A | 23 |
Data Center and AI
DCAI delivers industry-leading workload-optimized solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. We are uniquely positioned to deliver solutions to help solve our customers’ most complex challenges with the depth and breadth of our hardware and software portfolio combined with silicon and platforms, advanced packaging, and at-scale manufacturing made possible by being the world’s only IDM at scale. Our customers and partners include cloud hyperscalers, MNCs, small and medium-sized businesses, independent software vendors, systems integrators, communications service providers, and governments around the world.
| DCAI Revenue $B | DCAI Operating Income (Loss) $B |


| Revenue Summary |
| Q1 2023 vs. Q1 2022 |
Revenue was $3.7 billion, down $2.4 billion from Q1 2022, driven by a decrease in server revenue. Server volume decreased 50% in Q1 2023, due to lower demand and from customers tempering purchases to reduce existing inventories in a softening data center market. The decrease in server revenue was partially offset by an increase in revenue from the FPGA product line.
| Operating Income (Loss) Summary |
We had an operating loss of $518 million, compared to operating income of $1.4 billion in Q1 2022.
| (In Millions) | ||||||||
| $ | (518) | Q1 2023 DCAI Operating Income (Loss) | ||||||
| (1,935) | Lower server product margin due to lower server revenue, partially offset by an increase in product margin from higher DCAI other product revenue | |||||||
| (257) | Higher server unit cost from increased mix of 10nm SuperFin products | |||||||
| (154) | Higher period charges related to excess capacity charges | |||||||
| 199 | Lower operating expenses driven by various cost-cutting measures | |||||||
| 193 | Lower period charges primarily driven by a decrease in product ramp costs | |||||||
| 135 | Lower period charges driven by the sell-through of previously reserved inventory | |||||||
| (92) | Other | |||||||
| $ | 1,393 | Q1 2022 DCAI Operating Income (Loss) |
![]() | MD&A | 24 |
Network & Edge
NEX lifts the world's networks and edge compute systems from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. We work with partners and customers to deliver and deploy intelligent edge platforms that allow software developers to achieve agility and to drive automation using AI for efficient operations while securing the integrity of their data at the edge. We have a broad portfolio of hardware and software platforms, tools, and ecosystem partnerships for the rapid digital transformation happening from the cloud to the edge. We are leveraging our core strengths in process, software, and manufacturing at scale to grow traditional markets and to accelerate entry into emerging ones.
| NEX Revenue $B | NEX Operating Income (Loss) $B |


| Revenue Summary |
| Q1 2023 vs. Q1 2022 |
Revenue was $1.5 billion, down $650 million from Q1 2022, as customers tempered purchases to reduce existing inventories and adjust to a lower demand environment for Edge, Network Xeon and Ethernet products.
| Operating Income (Loss) Summary |
We had an operating loss of $300 million, compared to operating income of $416 million in Q1 2022.
| (In Millions) | ||||||||||||||
| $ | (300) | Q1 2023 NEX Operating Income (Loss) | ||||||||||||
| (475) | Lower product margin from lower Edge, Network Xeon, and Ethernet revenue | |||||||||||||
| (139) | Higher period charges driven by inventory reserves taken in Q1 2023 | |||||||||||||
| (102) | Other, including lower operating expenses driven by various cost-cutting measures | |||||||||||||
| $ | 416 | Q1 2022 NEX Operating Income (Loss) |
![]() | MD&A | 25 |
Mobileye
Mobileye is a global leader in driving assistance and self-driving solutions. Our product portfolio is designed to encompass the entire stack required for assisted and autonomous driving, including compute platforms, computer vision, and machine learning-based perception, mapping and localization, driving policy, and active sensors in development. We pioneered ADAS technology more than 20 years ago, and have continuously expanded the scope of our ADAS offerings while leading the evolution to autonomous driving solutions. Our unique assets in ADAS allow for building a scalable self-driving stack that meets the requirements for both robotaxi and consumer-owned autonomous vehicles. Our customers and strategic partners include major global original equipment manufacturers, Tier 1 automotive system integrators, and public transportation operators.
| Mobileye Revenue $B | Mobileye Operating Income $B |


| Revenue and Operating Income Summary |
| Q1 2023 vs. Q1 2022 |
Revenue was $458 million, up $64 million from Q1 2022 primarily driven by higher demand for EyeQ® products and Mobileye SuperVision* systems. Operating income was $123 million, down $25 million from Q1 2022, primarily due to increased investments in leadership products.
![]() | MD&A | 26 |
Intel Foundry Services
As the first Open System Foundry, we offer customers differentiated full stack solutions created from the best of Intel and the foundry industry ecosystem, delivered from a secure and sustainable source of supply with an array of flexible business models to enable customers to lead in their industry. In addition to a world-class foundry offering enabled by a rich ecosystem, customers have access to our expertise and technologies, including cores, accelerators, and advanced packaging such as Embedded Multi-die Interconnect Bridge. Our early customers and strategic partners include traditional fabless customers, cloud service providers, automotive customers, and military, aerospace, and defense firms. We also offer mask-making equipment for advanced lithography used by many of the world’s leading-edge foundries.
| IFS Revenue $B | IFS Operating Income (Loss) $B |


| Revenue and Operating Income (Loss) Summary |
| Q1 2023 vs. Q1 2022 |
Revenue was $118 million, down $38 million from Q1 2022 driven by lower sales of multi-beam mask writer tools. We had an operating loss of $140 million, compared to an operating loss of $23 million in Q1 2022, primarily due to increased factory startup costs.
![]() | MD&A | 27 |
| Consolidated Condensed Results of Operations | |||||
| Three Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Q1 2023 | Q1 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||
| (In Millions, Except Per Share Amounts) | Amount | % of Net Revenue | Amount | % of Net Revenue | ||||||||||||||||||||||||||||||||||||||||||||||
| Net revenue | $ | 11,715 | 100.0 | % | $ | 18,353 | 100.0 | % | ||||||||||||||||||||||||||||||||||||||||||
| Cost of sales | 7,707 | 65.8 | % | 9,109 | 49.6 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Gross margin | 4,008 | 34.2 | % | 9,244 | 50.4 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Research and development | 4,109 | 35.1 | % | 4,362 | 23.8 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Marketing, general, and administrative | 1,303 | 11.1 | % | 1,752 | 9.5 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and other charges | 64 | 0.5 | % | (1,211) | (6.6) | % | ||||||||||||||||||||||||||||||||||||||||||||
| Operating income (loss) | (1,468) | (12.5) | % | 4,341 | 23.7 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Gains (losses) on equity investments, net | 169 | 1.4 | % | 4,323 | 23.6 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Interest and other, net | 141 | 1.2 | % | 997 | 5.4 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Income (loss) before taxes | (1,158) | (9.9) | % | 9,661 | 52.6 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Provision for taxes | 1,610 | 13.7 | % | 1,548 | 8.4 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | (2,768) | (23.6) | % | 8,113 | 44.2 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Less: Net income (loss) attributable to non-controlling interests | (10) | (0.1) | % | — | — | % | ||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) attributable to Intel | $ | (2,758) | (23.5) | % | $ | 8,113 | 44.2 | % | ||||||||||||||||||||||||||||||||||||||||||
| Earnings (loss) per share attributable to Intel—diluted | $ | (0.66) | $ | 1.98 | ||||||||||||||||||||||||||||||||||||||||||||||
![]() | MD&A | 28 |
Revenue
| Segment Revenue Walk $B | |||||||||||

Q1 2023 results were impacted by an uncertain macroeconomic environment, with slowing consumer and enterprise demand, persistent inflation, and higher interest rates, that we believe impacts our target markets and creates a high level of uncertainty with our customers. We believe CCG, DCAI, and NEX customers, among others, tempered purchases to reduce their existing inventories and adjust to the macroeconomic uncertainty. We expect this macroeconomic uncertainty and the challenging market environment will continue during 2023.
Q1 2023 vs. Q1 2022
Our Q1 2023 revenue was $11.7 billion, down $6.6 billion or 36% from Q1 2022. CCG revenue decreased 38% from Q1 2022 due to lower notebook and desktop volumes on lower demand, while notebook ASPs decreased due to a higher mix of small core and older generation products. DCAI revenue decreased 39% from Q1 2022 due to lower server volume resulting from a softening data center market, partially offset by an increase in revenue from the FPGA product line. NEX revenue decreased 30% from Q1 2022, due to lower demand for Edge, Network Xeon, and Ethernet products.
Incentives offered to certain customers to compete in the market, accelerate purchases, and to strategically position our products with customers for market segment share purposes, particularly in CCG, contributed approximately $900 million to our revenue during the first quarter of 2023, the impacts of which were contemplated in our financial guidance for Q2 2023 as included in our Form 8-K dated April 27, 2023.
![]() | MD&A | 29 |
Gross Margin
We derived most of our overall gross margin in Q1 2023 from the sale of products in the CCG and DCAI operating segments. Our overall gross margin dollars in Q1 2023 decreased by $5.2 billion, or 57% compared to Q1 2022.
| Gross Margin $B | ||
(Percentages in chart indicate gross margin as a percentage of total revenue)

| (In Millions) | ||||||||
| $ | 4,008 | Q1 2023 Gross Margin | ||||||
| (2,358) | Lower product margin primarily from lower notebook and desktop revenue | |||||||
| (1,935) | Lower server product margin due to lower revenue, partially offset by an increase in product margin from higher DCAI other product revenue | |||||||
| (475) | Lower product margin from lower Edge, Network Xeon, and Ethernet revenue | |||||||
| (421) | Higher unit cost primarily from increased mix of Intel 7 and 10nm SuperFin products | |||||||
| (352) | Higher period charges related to excess capacity charges | |||||||
| 444 | Lower period charges primarily driven by a decrease in product ramp costs | |||||||
| (139) | Other | |||||||
| $ | 9,244 | Q1 2022 Gross Margin |
![]() | MD&A | 30 |
Effective January 2023, we increased the estimated useful life of certain production machinery and equipment from 5 years to 8 years. We estimate this change resulted in an approximate $360 million increase to gross margin, an approximate $100 million decrease in R&D expenses, and an approximate $525 million decrease in ending inventory values in Q1 2023 when compared to what the impact would have been using the estimated useful life in place prior to this change.
When compared to the estimated useful life in place as of the end of 2022, we expect total depreciation expense in 2023 to be reduced by $4.1 billion. We expect this change will result in an approximately $2.3 billion increase to gross margin, a $400 million decrease in R&D expenses, and a $1.4 billion decrease in ending inventory values.
Operating Expenses
Total R&D and MG&A expenses for Q1 2023 were $5.4 billion, down 11% from Q1 2022. These expenses represent 46.2% of revenue for Q1 2023 and 33.3% of revenue for Q1 2022. In support of our strategy, described in our 2022 Form 10-K, we continue to make significant investments to accelerate our process technology roadmap. This requires continued investments in R&D and focused efforts to attract and retain talent. We have implemented certain cost-cutting measures while we continue to improve our product execution.
| Research and Development $B | Marketing, General, and Administrative $B | ||||||||||
(Percentages in chart indicate operating expenses as a percentage of total revenue)

| Research and Development |
Q1 2023 vs. Q1 2022
| R&D decreased by $253 million, or 6%, driven by the following: | |||||
| - | Lower incentive-based cash compensation | ||||
| + | Increased investments in our process technology roadmap and additional corporate spending to drive strategic growth, partially offset by the effects of various cost-cutting measures | ||||
| Marketing, General, and Administrative |
Q1 2023 vs. Q1 2022
| MG&A decreased by $449 million, or 26%, driven by the following: | |||||
| - | Lower corporate spending as a result of various cost-cutting measures | ||||
| - | Lower incentive-based cash compensation | ||||
![]() | MD&A | 31 |
Restructuring and Other Charges
| (In Millions) | Q1 2023 | Q1 2022 | |||||||||||||||||||||||||||
| Employee severance and benefit arrangements | $ | (39) | $ | 5 | |||||||||||||||||||||||||
| Litigation charges and other | 77 | (1,216) | |||||||||||||||||||||||||||
| Asset impairment charges | 26 | — | |||||||||||||||||||||||||||
| Total restructuring and other charges | $ | 64 | $ | (1,211) |
The 2022 Restructuring Program was approved in Q3 2022 to rebalance our workforce and operations to create efficiencies and improve our product execution in alignment with our strategy. During Q1 2023, activity related to the 2022 Restructuring Program substantially related to cash settlement of previously accrued employee severance and benefit arrangements and we expect any additional actions pursuant to the 2022 Restructuring Program to be substantially completed by the end of 2023, but this is subject to change. We expect that our 2022 Restructuring Plan, in conjunction with other initiatives, will reduce our cost structure and allow us to reinvest certain of these cost savings in resources and capacity to develop, manufacture, market, sell, and deliver our products in furtherance of our strategy.
Litigation charges and other includes a $1.2 billion benefit in Q1 2022 from the annulled penalty related to an EC fine that was recorded and paid in 2009.
Gains (Losses) on Equity Investments and Interest and Other, Net
| (In Millions) | Q1 2023 | Q1 2022 | |||||||||||||||||||||||||||||||||||||||
| Ongoing mark-to-market adjustments on marketable equity securities | $ | 188 | $ | (430) | |||||||||||||||||||||||||||||||||||||
| Observable price adjustments on non-marketable equity securities | 10 | 71 | |||||||||||||||||||||||||||||||||||||||
| Impairment charges | (36) | (23) | |||||||||||||||||||||||||||||||||||||||
| Sale of equity investments and other | 7 | 4,705 | |||||||||||||||||||||||||||||||||||||||
| Total gains (losses) on equity investments, net | $ | 169 | $ | 4,323 | |||||||||||||||||||||||||||||||||||||
| Interest and other, net | $ | 141 | $ | 997 |
Gains (losses) on equity investments, net
Ongoing mark-to-market adjustments for Q1 2023 and Q1 2022 were primarily related to our interest in Montage Technology, Co. Ltd and others.
In Q1 2022, the sale of McAfee to an investor group was completed and we received $4.6 billion in cash for the sale of our remaining share of McAfee, recognizing a $4.6 billion gain in sale of equity investments and other.
Interest and other, net
In 2022, we recognized a gain of $1.0 billion from the first closing of the divestiture of our NAND memory business.
Provision for Taxes
| (In Millions) | Q1 2023 | Q1 2022 | ||||||||||||||||||||||||
| Income (loss) before taxes | $ | (1,158) | $ | 9,661 | ||||||||||||||||||||||
| Provision for taxes | $ | 1,610 | $ | 1,548 | ||||||||||||||||||||||
| Effective tax rate | (139.0) | % | 16.0 | % |
In Q1 2023, we recognized a provision for taxes as we applied our estimated annual effective tax rate to our year-to-date measure of ordinary income (loss) before taxes, which reflects a higher proportion of our income being taxed in non-US jurisdictions. Our effective tax rate decreased in Q1 2023 compared to Q1 2022, due to a loss before taxes, the application of our estimated annual effective tax rate, and the unfavorable tax rate effects associated with the gains recognized in Q1 2022 from the equity sale of McAfee and the divestiture of our NAND memory business.
![]() | MD&A | 32 |
Liquidity and Capital Resources
We consider the following when assessing our liquidity and capital resources:
| (In Millions) | Apr 1, 2023 | Dec 31, 2022 | ||||||||||||
| Cash and cash equivalents | $ | 8,232 | $ | 11,144 | ||||||||||
| Short-term investments | 19,302 | 17,194 | ||||||||||||
| Loans receivable and other | 64 | 463 | ||||||||||||
| Total cash and investments****1 | $ | 27,598 | $ | 28,801 | ||||||||||
| Total debt | $ | 50,273 | $ | 42,051 |
We believe we have sufficient sources of funding to meet our business requirements for the next 12 months and in the longer term. Cash generated by operations, supplemented by our total cash and investments1, as shown in the preceding table, is our primary source of liquidity for funding our strategic business requirements. Our short-term funding requirements include capital expenditures for worldwide manufacturing and assembly and test, including investments in our process technology roadmap; working capital requirements; and potential and pending acquisitions, strategic investments, and dividends. This includes a commitment of $5.4 billion associated with our pending acquisition of Tower. Our long-term funding requirements incrementally contemplate investments in significant manufacturing expansion plans and investments to accelerate our process technology.
Our cash and investments and related cash flows may be affected by certain discretionary actions we may take with customers and suppliers to accelerate or delay certain cash receipts or payments to manage liquidity for our strategic business requirements. These actions can include, among others, negotiating with suppliers to optimize our payment terms and conditions, adjusting the timing of cash flows associated with customer sales programs and collections, managing inventory levels and purchasing practices, and selling certain of our accounts receivables on a non-recourse basis to third party financial institutions.
We expect to benefit from government incentives, and any incentives above our current expectations would enable us to increase the pace and size of our IDM 2.0 investments. Conversely, incentives below our expectations would increase our anticipated cash requirements.
In Q1 2023, we declared a reduced quarterly dividend on our common stock. This dividend reduction reflects our deliberate approach to capital allocation, is expected to support the critical investments needed to execute our business strategy, and is designed to position us to create long-term value.
In Q1 2023, we issued a total of $11.0 billion aggregate principal amount of senior notes. We intend to use the proceeds from the offering for general corporate purposes, including, but not limited to, refinancing of outstanding debt and funding for working capital and capital expenditures. We also amended both our 5-year $5.0 billion revolving credit facility, extending the maturity date by one year to March 2028, and our 364-day $5.0 billion credit facility agreement, extending the maturity date to March 2024. We have other potential sources of liquidity include our commercial paper program and our automatic shelf registration statement on file with the SEC, pursuant to which we may offer an unspecified amount of debt, equity, and other securities. Under our commercial paper program, we have an ongoing authorization from our Board of Directors to borrow up to $10.0 billion and, as of April 1, 2023 we had $1.0 billion of commercial paper obligations outstanding. As of April 1, 2023, we had no outstanding borrowings on the revolving credit facilities.
We maintain a diverse investment portfolio that we continually analyze based on issuer, industry, and country. Substantially all of our investments in debt instruments and financing receivables were in investment-grade securities.
| Cash from (used for) Operations $B | Capital Expenditures $B | Dividends $B |



1 See "Non-GAAP Financial Measures" within MD&A.
![]() | MD&A | 33 |
| Three Months Ended | ||||||||||||||
| (In Millions) | Apr 1, 2023 | Apr 2, 2022 | ||||||||||||
| Net cash provided by (used for) operating activities | $ | (1,785) | $ | 5,891 | ||||||||||
| Net cash used for investing activities | (8,521) | (2,639) | ||||||||||||
| Net cash provided by (used for) financing activities | 7,394 | (1,864) | ||||||||||||
| Net increase (decrease) in cash and cash equivalents | $ | (2,912) | $ | 1,388 |
Operating Activities
Operating cash flows consist of net income adjusted for certain non-cash items and changes in certain assets and liabilities.
The decrease in cash provided by operations in the first three months of 2023 was primarily driven by our net operating loss in comparison to our net operating income for the first three months of 2022.
Investing Activities
Investing cash flows consist primarily of capital expenditures; investment purchases, sales, maturities, and disposals; and proceeds from divestitures.
Cash used for investing activities was higher in the first three months of 2023 compared to the first three months of 2022, primarily due to the absence of proceeds from the divestiture of our NAND business and proceeds for our remaining share of McAfee, both of which occurred in the first three months of 2022; as well as higher capital expenditures in the first three months of 2023. These unfavorable cash impacts during the first three months of 2023 were partially offset by the favorable cash impacts of lower purchases of short-term investments, net of maturities and sales, during the first three months of 2023.
Financing Activities
Financing cash flows consist primarily of payment of dividends to stockholders, issuance and repayment of short-term and long-term debt, and proceeds from the sale of shares of common stock through employee equity incentive plans.
Cash provided by financing activities in the first three months of 2023 compared to cash used for financing activities in the first three months of 2022 was primarily due to net proceeds from our debt issuance, partially offset by commercial paper repayments, during the first three months of 2023.
Non-GAAP Financial Measures
In addition to disclosing financial results in accordance with US GAAP, this document contains references to the non-GAAP financial measures below. We believe these non-GAAP financial measures provide investors with useful supplemental information about our operating performance, enable comparison of financial trends and results between periods where certain items may vary independent of business performance, and allow for greater transparency with respect to key metrics used by management in operating our business and measuring our performance. These non-GAAP financial measures are used in our performance-based RSUs and our cash bonus plans.
Our non-GAAP financial measures reflect adjustments based on one or more of the following items, as well as the related income tax effects. Beginning in 2023, income tax effects are calculated using a fixed long-term projected tax rate across all adjustments. We project this long-term non-GAAP tax rate on an annual basis using a five-year non-GAAP financial projection that excludes the income tax effects of each adjustment. The projected non-GAAP tax rate also considers factors such as our tax structure, our tax positions in various jurisdictions, and key legislation in significant jurisdictions where we operate. This long-term non-GAAP tax rate may be subject to change for a variety of reasons, including the rapidly evolving global tax environment, significant changes in our geographic earnings mix, or changes to our strategy or business operations. Management uses this non-GAAP tax rate in managing internal short- and long-term operating plans and in evaluating our performance; we believe this approach facilitates comparison of our operating results and provides useful evaluation of our current operating performance. Prior-period non-GAAP results have been retroactively adjusted to reflect this updated approach.
These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with US GAAP, and the financial results calculated in accordance with US GAAP and reconciliations from these results should be carefully evaluated.
![]() | MD&A | 34 |
| Non-GAAP adjustment or measure | Definition | Usefulness to management and investors | ||||||
| Acquisition-related adjustments | Amortization of acquisition-related intangible assets consists of amortization of intangible assets such as developed technology, brands, and customer relationships acquired in connection with business combinations. Charges related to the amortization of these intangibles are recorded within both cost of sales and MG&A in our US GAAP financial statements. Amortization charges are recorded over the estimated useful life of the related acquired intangible asset, and thus are generally recorded over multiple years. | We exclude amortization charges for our acquisition-related intangible assets for purposes of calculating certain non-GAAP measures because these charges are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions. These adjustments facilitate a useful evaluation of our current operating performance and comparison to our past operating performance and provide investors with additional means to evaluate cost and expense trends. | ||||||
| Share-based compensation | Share-based compensation consists of charges related to our employee equity incentive plans. | We exclude charges related to share-based compensation for purposes of calculating certain non-GAAP measures because we believe these adjustments provide better comparability to peer company results and because these charges are not viewed by management as part of our core operating performance. We believe these adjustments provide investors with a useful view, through the eyes of management, of our core business model, how management currently evaluates core operational performance, and additional means to evaluate expense trends, including in comparison to other peer companies. | ||||||
| Restructuring and other charges | Restructuring charges are costs associated with a formal restructuring plan and are primarily related to employee severance and benefit arrangements. Other charges may include periodic goodwill and asset impairments, certain pension charges, and costs associated with restructuring activity, and in Q1 2022 includes a benefit related to the annulled EC fine. | We exclude restructuring and other charges, including any adjustments to charges recorded in prior periods, for purposes of calculating certain non-GAAP measures because these costs do not reflect our core operating performance. These adjustments facilitate a useful evaluation of our core operating performance and comparisons to past operating results and provide investors with additional means to evaluate expense trends. | ||||||
| Gains (losses) from divestiture | Gains (losses) are recognized at the close of a divestiture, or over a specified deferral period when deferred consideration is received at the time of closing. Based on our ongoing obligation under the NAND wafer manufacturing and sale agreement entered into in connection with the first closing of the sale of our NAND memory business on December 29, 2021, a portion of the initial closing consideration was deferred and will be recognized between first and second closing. | We exclude gains or losses resulting from divestitures for purposes of calculating certain non-GAAP measures because they do not reflect our current operating performance. These adjustments facilitate a useful evaluation of our current operating performance and comparisons to past operating results. | ||||||
| (Gains) losses on equity investments, net | (Gains) losses on equity investments, net consists of ongoing mark-to-market adjustments on marketable equity securities, observable price adjustments on non-marketable equity securities, related impairment charges, and the sale of equity investments and other. | We exclude these non-operating gains and losses for purposes of calculating certain non-GAAP measures because it provides better comparability between periods. The exclusion reflects how management evaluates the core operations of the business. | ||||||
| Adjusted free cash flow | We reference a non-GAAP financial measure of adjusted free cash flow, which is used by management when assessing our sources of liquidity, capital resources, and quality of earnings. Adjusted free cash flow is operating cash flow adjusted for (1) additions to property, plant and equipment, net of proceeds from capital grants and partner contributions, (2) payments on finance leases, and (3) proceeds from the McAfee equity sale. | This non-GAAP financial measure is helpful in understanding our capital requirements and sources of liquidity by providing an additional means to evaluate the cash flow trends of our business. Since the 2017 divestiture, McAfee equity distributions and sales contributed to prior operating and free cash flow, and while the McAfee equity sale in Q1 2022 would have typically been excluded from adjusted free cash flow as an equity sale, we believe including the sale proceeds in adjusted free cash flow facilitate a better, more consistent comparison to past presentations of liquidity. | ||||||
| Total cash and investments | Total cash and investments is used by management when assessing our sources of liquidity, which include cash and cash equivalents, short-term investments, and loans receivable and other. | This non-GAAP measure is helpful in understanding our capital resources and liquidity position. | ||||||
![]() | MD&A | 35 |
Following are the reconciliations of our most comparable US GAAP measures to our non-GAAP measures presented:
| Three Months Ended | ||||||||||||||||||||||||||
| Apr 1, 2023 | Apr 2, 2022 | |||||||||||||||||||||||||
| Gross margin percentage | 34.2 | % | 50.4 | % | ||||||||||||||||||||||
| Acquisition-related adjustments | 2.8 | % | 1.9 | % | ||||||||||||||||||||||
| Share-based compensation | 1.4 | % | 0.8 | % | ||||||||||||||||||||||
| Non-GAAP gross margin percentage | 38.4 | % | 53.1 | % | ||||||||||||||||||||||
| Earnings (loss) per share attributable to Intel—diluted | $ | (0.66) | $ | 1.98 | ||||||||||||||||||||||
| Acquisition-related adjustments | 0.09 | 0.10 | ||||||||||||||||||||||||
| Share-based compensation | 0.18 | 0.17 | ||||||||||||||||||||||||
| Restructuring and other charges | 0.01 | (0.30) | ||||||||||||||||||||||||
| (Gains) losses on equity investments, net | (0.04) | (1.05) | ||||||||||||||||||||||||
| (Gains) losses from divestiture | (0.01) | (0.27) | ||||||||||||||||||||||||
| Total adjustments attributable to non-controlling interest | — | — | ||||||||||||||||||||||||
| Income tax effects | 0.39 | 0.24 | ||||||||||||||||||||||||
| Non-GAAP earnings (loss) per share attributable to Intel—diluted | $ | (0.04) | $ | 0.87 | ||||||||||||||||||||||
| Three Months Ended | ||||||||||||||
| (In Millions) | Apr 1, 2023 | Apr 2, 2022 | ||||||||||||
| Net cash provided by (used for) operating activities | $ | (1,785) | $ | 5,891 | ||||||||||
| Net additions to property, plant and equipment | (6,964) | (4,603) | ||||||||||||
| Payments on finance leases | (15) | (299) | ||||||||||||
| Sale of equity investment | — | 4,561 | ||||||||||||
| Adjusted free cash flow | $ | (8,764) | $ | 5,550 | ||||||||||
| Net cash used for investing activities | $ | (8,521) | $ | (2,639) | ||||||||||
| Net cash provided by (used for) financing activities | $ | 7,394 | $ | (1,864) | ||||||||||
![]() | MD&A | 36 |
| Other Key Information | |||||
Previous: Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations: · Next: Item 3. Quantitative and Qualitative Disclosures About Market Risk
